[spacer image]
BD
United StatesUnited States
Blood & Urine Collection
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
Newsletters
LabNotes Tech Talk
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]

Did you know?
[spacer image] BD began manufacturing sterile disposable products in 1961, when it introduced the BD Plastipak™ syringe. Learn more about BD's history » [spacer image]
[spacer image]


Products
Email Page Print
[spacer image]
Molecular Diagnostics & Proteomics

BD Vacutainer® CPT™ Cell Preparation Tube with Sodium Heparin

Performance Characteristics

Table 2 shows the repeatability of sample preparation using the BD Vacutainer® CPT™ Tube system which was tested and compared to the FICOLL™ HYPAQUE™ method. Ten samples of one donor's pooled blood were centrifuged and assayed in duplicate for each method. No final washing steps were performed. The samples were resuspended to equal final volumes. Estimates of variability due to repeated measurements are shown for within tube and between tubes. Within tube variation was measured by taking duplicate readings from each tube.

Table 2

Repeatability of recovered Mononuclear Cell values, (FICOLL™ HYPAQUE™ versus BD Vacutainer® CPT™ Tube Method) (7)
PARAMETER
% VARIATION
AVG WITHIN TUBE* BETWEEN TUBE
% SD CV SD CV
Recovery          
BD Vacutainer® CPT™ (n=9) 79.5 3.41 4.3 6.25 7.9
FICOLL™ HYPAQUE™ (n=10) 73.3 3.55 4.8 2.22 3.0
Purity
BD Vacutainer® CPT™ (n=9)          
Total Mononuclear Cells 94.6 0.69 0.7 1.48 1.6
Lymphocytes 72.6 0.93 1.3 0.87 1.2
Monocytes 22.0 0.94 4.3 0.99 4.5
FICOLL™ HYPAQUE™ (n=10)          
Total Mononuclear Cells 96.5 0.66 0.7 1.46*** 1.5
Lymphocytes 80.5 0.82 1.0 0.91 1.1
Monocytes 16.0 1.06 6.6 1.30 8.2
RBC Contamination
BD Vacutainer® CPT™ (n=9) 28.4 1.36 4.8 13.73 48.5
FICOLL™ HYPAQUE™ (n=10) 14.9 1.21 8.1 5.85 39.3
Granulocyte Contamination
BD Vacutainer® CPT™ (n=9) 5.4 0.62 11.4 1.49 27.3
FICOLL™ HYPAQUE™ 3.5 0.57 16.2 1.47 42.1

Footnotes:
*** Within tube variation was determined by taking duplicate readings from each tube.
*** A duplicate reading was lost, so only 9 samples could be compared.
*** With one apparently unusual tube deleted, SD=0.45.
• Parameters defined in Table 1.
• Viability was 100% in all samples since no cell wash steps were performed.
• AVG - Mean Number
• SD - Standard Deviation
• CV - Coefficient of Variation
• n - # of tubes


FICOLL is a trademark of Amersham Biosciences AB
HYPAQUE is a trademark of Amersham Health AS

About BD Vacutainer® CPT™ Cell Preparation Tube with Sodium Heparin

Intended Use

Summary & Explanation

Test Principles

Reagents, Supplies & Equipment

Warnings & Precautions

Venipuncture Technique

Procedure

Limitations

Expected Results

Performance Characteristics

Troubleshooting

Product Insert [PDF]

References

How To Order

Contact Us

More Molecular Diagnostics & Proteomics products



 

[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]